Quality & Patient Safety

Medication safety group revises its list of high-risk medications

Patient Safety Monitor Alert, February 18, 2004

Want to receive articles like this one in your inbox? Subscribe to Patient Safety Monitor Alert!

The Institute for Safe Medication Practices (ISMP) has updated its list of high-alert medications. Its new list identifies 33 different drugs or drug classifications that practitioners have frequently considered to be high-alert medications (http://www.ismp.org).

A high-alert medication is a drug that has a high risk of causing injury to patients when misused. Errors with the drugs are not necessarily more common than with other drugs, but their consequences can be more devastating.

The ISMP expects organizations to use the list to identify medications that require special safeguards to reduce the risk of errors. Safeguards may include limiting access to certain drugs, using auxiliary labels and automated alerts, and standardizing how the drugs are ordered, prepared, and administered.

The updated list includes the following:

Class/category of medications

  • adrenergic agonists, IV (e.g., epinephrine)
  • adrenergic antagonists, IV (e.g., propranolol)
  • anesthetic agents, general, inhaled and IV (e.g., propofol)
  • cardioplegic solutions
  • chemotherapeutic agents, parenteral and oral
  • dextrose, hypertonic, 20% or greater
  • dialysis solutions, peritoneal and hemodialysis
  • epidural or intrathecal medications
  • glycoprotein IIb/IIIa inhibitors (e.g., eptifibatide)
  • hypoglycemics, oral
  • inotropic medications, IV (e.g., digoxin, milrinone)
  • liposomal forms of drugs (e.g., liposomal amphotericin B)
  • moderate sedation agents, IV (e.g., midazolam)
  • moderate sedation agents, oral, for children (e.g., chloral hydrate)
  • narcotics/opiates, IV and oral (including liquid concentrates, immediate- and sustained- release)
  • neuromuscular blocking agents (e.g., succinylcholine)
  • radiocontrast agents, IV
  • thrombolytics/fibrinolytics, IV (e.g., tenecteplase)
  • total parenteral nutrition solutions
Specific medications
  • IV amiodarone
  • colchicine injection
  • heparin, low molecular weight, injection
  • heparin, unfractionated, IV
  • insulin, subcutaneous and IV
  • IV lidocaine
  • magnesium sulfate injection
  • methotrexate, oral, non-oncologic use
  • nesiritide
  • nitroprusside, sodium, for injection
  • potassium chloride for injection concentrate
  • potassium phosphates injection
  • sodium chloride injection, hypertonic, more than 0.9% concentration
  • warfarin



Want to receive articles like this one in your inbox? Subscribe to Patient Safety Monitor Alert!

    Patient Safety Monitor
  • Patient Safety Monitor

    As part of your Patient Safety Monitor membership, you'll receive Briefings on Patient Safety. In this 12-page monthly...

  • Patient Safety Monitor Alert

    This e-mail newsletter provides healthcare professionals with the latest patient safety news, while offering useful...

  • Patient Safety Quality Monthly

    Ken Rohde, Senior Consultant for The Greeley Company with over 25 years of experience in quality management. His roles in...

  • Occurrence Reporting:

    Take advantage of the information occurrence reports provide and make sustainable enhancements at your facility. Expert...

Most Popular

Related Articles